# FDA 483 - Quincy Bioscience Holding Company, Inc. - December 22, 2011

Source: https://www.globalkeysolutions.net/records/483/quincy-bioscience-holding-company-inc/c3f16c09-a16b-42f4-9a93-9afab6992546

> FDA 483 for Quincy Bioscience Holding Company, Inc. on December 22, 2011. Product: other. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Quincy Bioscience Holding Company, Inc.
- Inspection Date: 2011-12-22
- Product Type: other
- Office Name: Minneapolis District Office
- Summary: An FDA inspection of Quincy Bioscience Manufacturing Inc. in Middleton, WI, revealed significant deficiencies in their dietary supplement manufacturing processes. The firm failed to verify finished product identity, adhere to master production records, follow laboratory procedures, establish adequate in-process specifications, and maintain complete master manufacturing records. These issues indicate a lack of robust quality control and documentation for their products, including Prevagen.

## Related Officers

- [Investigator](https://www.globalkeysolutions.net/people/jasjeet-k-sekhon/0dfa8aa8-ebe5-4182-81dc-8027667326f4)
- [Research Specialist II](https://www.globalkeysolutions.net/people/justin-a-boyd/796c9c9d-02db-486c-bdca-cc259066a0e2)

Company: https://www.globalkeysolutions.net/companies/quincy-bioscience-holding-company-inc/462623f1-e31a-4da0-832d-824f0f80f91f

Office: https://www.globalkeysolutions.net/offices/minneapolis-district-office/c79fc8dc-f884-48fc-ba80-2947f662511d